FY25 EBITDA target around $1m, rising quickly to $7.4m in FY26 as they continue to scale (looking like iTrack Advance will be very profitable once they achieve a good amount of scale)
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
FY25 EBITDA target around $1m, rising quickly to $7.4m in FY26...
-
-
- There are more pages in this discussion • 458 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.52M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 94491 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 157581 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 94491 | 0.190 |
3 | 225980 | 0.185 |
3 | 171691 | 0.180 |
5 | 114937 | 0.175 |
3 | 8900 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 157581 | 3 |
0.205 | 15050 | 1 |
0.210 | 223212 | 2 |
0.215 | 304291 | 5 |
0.220 | 2000 | 1 |
Last trade - 10.04am 13/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
Day chart unavailable